|Bid||3.10 x 200|
|Ask||4.58 x 500|
|Day's Range||3.62 - 3.87|
|52 Week Range||1.22 - 5.55|
|PE Ratio (TTM)||-11.17|
|Earnings Date||May 18, 2017 - May 19, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
Cleveland BioLabs, Inc. today reported financial results and development progress for the first quarter ended March 31, 2017.
NEW YORK, NY / ACCESSWIRE / April 20, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)